View Single Post
Old 12-14-2015, 03:08 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 20,143
DCIS patients receiving anastrozole reported symptoms different from those receiving

Both groups reported similar quality of life. Analysis of patient-reported outcomes (PRO), a secondary endpoint of the phase III, NSABP B-35 clinical trial, in which anastrazole and tamoxifen were...

More...
News is offline   Reply With Quote